FUNDAMENTALS · Fundamentals · IE Healthcare

Oneview Healthcare (ONE) Fundamentals 2026 — Revenue Analysis | SniperIQ

Oneview Healthcare (ONE) is a IE-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of A

50M, trading at A$0.17 on the ASX. This SniperIQ fundamentals page covers Oneview Healthcare's valuation, profitability (net margin -104.8%), revenue (€12M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapA
50M
Net Margin-104.8%
Revenue (FY25)€12M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Oneview Healthcare's market cap?

Oneview Healthcare (ONE) has a market capitalization of approximately A

50M, trading at A$0.17 on the ASX. Market cap moves with the live share price.

What is Oneview Healthcare's P/E ratio?

Oneview Healthcare's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 21.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Oneview Healthcare?

Oneview Healthcare runs a net profit margin of -104.8%, a gross margin of 61.8%, and an operating margin of -92.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Oneview Healthcare generate?

Oneview Healthcare reported revenue of €12M for fiscal year 2025, with net income of -€13M and earnings per share (EPS) of -0.0164. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Oneview Healthcare pay a dividend?

Oneview Healthcare does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Oneview Healthcare financially healthy?

Oneview Healthcare carries a debt-to-equity ratio of 0.30x and a current ratio of 1.30x, with a market beta of 0.83. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Oneview Healthcare a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Oneview Healthcare (ONE) the key facts are: market cap A

50M, revenue €12M, 52-week range 0.13-0.41. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Oneview Healthcare's full fundamentals live

Get Oneview Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Dimerix (DXB) fundamentals · Immunic (IMUX) fundamentals · Qatari German Company for Medical Devices (Q.P.S.C.) (QGMD.QA) fundamentals · Cardiol Therapeutics (CRDL) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons